148 related articles for article (PubMed ID: 10183946)
1. Treatment of congenital and acquired hemophilia patients by extracorporeal removal of antibodies to coagulation factors: a review of US clinical studies 1987-1990. Hemophilia Study Group.
Watt RM; Bunitsky K; Faulkner EB; Hart CM; Horan J; Ramstack JM; Viola JL; Yordy JR
Transfus Sci; 1992 Apr; 13(2):233-53. PubMed ID: 10183946
[TBL] [Abstract][Full Text] [Related]
2. Extracorporeal immunoadsorption for the treatment of coagulation inhibitors.
Franchini M; Sassi M; Dell'Anna P; Manzato F; Salvagno GL; Montagnana M; Zaffanello M; Targher G; Lippi G
Semin Thromb Hemost; 2009 Feb; 35(1):76-80. PubMed ID: 19308895
[TBL] [Abstract][Full Text] [Related]
3. Kinetic aspects of the removal of IgG and inhibitors in hemophiliacs using protein A immunoadsorption.
Gjörstrup P; Berntorp E; Larsson L; Nilsson IM
Vox Sang; 1991; 61(4):244-50. PubMed ID: 1776241
[TBL] [Abstract][Full Text] [Related]
4. Apheresis.
Nilsson IM; Freiburghaus C
Adv Exp Med Biol; 1995; 386():175-84. PubMed ID: 8851026
[TBL] [Abstract][Full Text] [Related]
5. Immunoadsorption for coagulation factor inhibitors.
Uehlinger J; Button GR; McCarthy J; Forster A; Watt R; Aledort LM
Transfusion; 1991; 31(3):265-9. PubMed ID: 2003328
[TBL] [Abstract][Full Text] [Related]
6. Immunoadsorption may provide a cost-effective approach to management of patients with inhibitors to FVIII.
Freedman J; Rand ML; Russell O; Davis C; Cheatley PL; Blanchette V; Garvey MB
Transfusion; 2003 Nov; 43(11):1508-13. PubMed ID: 14617307
[TBL] [Abstract][Full Text] [Related]
7. Immunoadsorption of factor VIII inhibitors.
Freedman J; Garvey MB
Curr Opin Hematol; 2004 Sep; 11(5):327-33. PubMed ID: 15666656
[TBL] [Abstract][Full Text] [Related]
8. Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb).
Jansen M; Schmaldienst S; Banyai S; Quehenberger P; Pabinger I; Derfler K; Hörl WH; Knöbl P
Br J Haematol; 2001 Jan; 112(1):91-7. PubMed ID: 11167789
[TBL] [Abstract][Full Text] [Related]
9. Protein A sepharose immunoadsorption: immunological and haemostatic effects in two cases of acquired haemophilia.
Guillet B; Kriaa F; Huysse MG; Proulle V; George C; Tchernia G; D'Oiron R; Laurian Y; Charpentier B; Lambert T; Dreyfus M
Br J Haematol; 2001 Sep; 114(4):837-44. PubMed ID: 11564072
[TBL] [Abstract][Full Text] [Related]
10. Extracorporeal immunoadsorption for the treatment of haemophilic patients with inhibitors to factor VIII or IX.
Knöbl P; Derfler K
Vox Sang; 1999; 77 Suppl 1():57-64. PubMed ID: 10529691
[TBL] [Abstract][Full Text] [Related]
11. Immunoadsorption with single-use columns for the management of bleeding in acquired hemophilia A: a series of nine cases.
Brzoska M; Krause M; Geiger H; Betz C
J Clin Apher; 2007; 22(4):233-40. PubMed ID: 17610289
[TBL] [Abstract][Full Text] [Related]
12. Acquired hemophilia.
Bouvry P; Recloux P
Haematologica; 1994; 79(6):550-6. PubMed ID: 7896216
[TBL] [Abstract][Full Text] [Related]
13. Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry.
Parameswaran R; Shapiro AD; Gill JC; Kessler CM;
Haemophilia; 2005 Mar; 11(2):100-6. PubMed ID: 15810910
[TBL] [Abstract][Full Text] [Related]
14. Acquired haemophilia syndrome: pathophysiology and therapy.
Elezović I
Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():64-8. PubMed ID: 20229686
[TBL] [Abstract][Full Text] [Related]
15. Immunoadsorption for pregnancy-associated severe acquired hemophilia.
Zeitler H; Ulrich-Merzenich G; Marquardt N; Oldenburg J; Goldmann G
Ther Apher Dial; 2014 Feb; 18(1):103-10. PubMed ID: 24499091
[TBL] [Abstract][Full Text] [Related]
16. Immunoadsorption for the Treatment of Acquired Hemophilia: New Observational Data, Systematic Review, and Meta-Analysis.
Esteves Pereira M; Bocksrucker C; Kremer Hovinga JA; Mueller M; Daskalakis M; Mansouri Taleghani B; Nagler M
Transfus Med Rev; 2021 Apr; 35(2):125-134. PubMed ID: 33518429
[TBL] [Abstract][Full Text] [Related]
17. Plasma exchange for acquired hemophilia: a case report.
Ogata H; Sakai S; Koiwa F; Tayama H; Kinugasa E; Ideura T; Akizawa T
Ther Apher; 1999 Nov; 3(4):320-2. PubMed ID: 10608727
[TBL] [Abstract][Full Text] [Related]
18. Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. French FEIBA Study Group. Factor Eight Bypassing Activity.
Negrier C; Goudemand J; Sultan Y; Bertrand M; Rothschild C; Lauroua P
Thromb Haemost; 1997 Jun; 77(6):1113-9. PubMed ID: 9241742
[TBL] [Abstract][Full Text] [Related]
19. Acquired inhibitors.
Cohen AJ; Kessler CM
Baillieres Clin Haematol; 1996 Jun; 9(2):331-54. PubMed ID: 8800509
[TBL] [Abstract][Full Text] [Related]
20. Options for treating acute bleeds in addition to bypassing agents: extracorporeal immunoadsorption, FVIII/FIX, desmopressin and antifibrinolytics.
Berntorp E
Haemophilia; 2006 Dec; 12 Suppl 6():62-5; discussion 65-6. PubMed ID: 17123396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
